Undoit Medical

Company Overview

Snapshot

Founded in January 2013 by Gershon Goldenberg, Undoit Medical operated with 1–10 employees. The company developed patented platform technologies for aesthetic treatments, holding one patent.

Business overview

Undoit Medical develops aesthetic treatment solutions for applications such as tattoo removal, stretch marks, melasma, skin rejuvenation, and acne scars. The company's core technologies include Trigation and 3VOTM, both patented platforms that utilize controlled mechanical trauma, transdermal vehiculation of active ingredients, and surface suction. These systems are designed for user-friendly operation, comprising a standalone unit with a computerized console and handpiece, alongside a disposable kit. Undoit Medical serves global markets within the Health Tech & Life Sciences sector, specifically targeting medical devices and medical treatment & therapeutics.

Company Intelligence Q&A

What is Undoit Medical's primary focus?

Undoit Medical focuses on developing aesthetic treatment solutions for various skin conditions, including tattoo removal, stretch marks, melasma, skin rejuvenation, and acne scars.

What are the key technologies developed by Undoit Medical?

Undoit Medical has developed two patented platform technologies: Trigation and 3VOTM. Both systems combine microneedling or dermal perforation with transdermal vehiculation and simultaneous suction for aesthetic treatments.

When was Undoit Medical founded?

Undoit Medical was founded in January 2013.

What is the operational status of Undoit Medical?

Undoit Medical ceased to operate in May 2024.

Does Undoit Medical hold any patents?

Yes, Undoit Medical holds one patent related to its aesthetic treatment technologies.